CORZ
Core Scientific, Inc./tx
NASDAQ · Technology · Software - Infrastructure · US
$13.73
+1.85%Year over year
Reported trailing growth
- Revenue
- +26.4%
- EBITDA
- —
- EBIT
- +3.9%
- EPS
- -75.8%
- Free cash flow
- —
- Operating cash flow
- +5984.7%
Forward estimates
Based on analyst estimates
- Revenue
- +129.0%
- EBITDA
- +114.2%
- EPS
- +102.2%
Three-year CAGR
- Revenue
- -20.7%
- EBITDA
- +82.0%
- EBIT
- —
- Net income
- +78.1%
- EPS
- +82.9%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026